April 7, 2011 -- Jilin Aodong Medicine Industry Group (?????????????) will make a small $2 million investment into Vital Therapies, a San Diego company that is developing a medical device for patients with liver failure. The initial $2 million investment will purchase a stake in Vital Therapies of between 5% and 6%. If Vital Therapies obtains SFDA approval for its device in the next six months, Aodong will invest an additional $25 million in Vital Therapies. More details....
Stock Symbol: (SHE: 000623)
